P. Michetti

Discipline

Psychologie (6) Sociologie (1) Histoire (1) Education (1)

Type de document

Articles (24) Recensions (3) Colloques et conférences (3)

Co-auteur

Date

Source

Mot-clé

Patients (18) Patients (18) maladie (14) maladie (12) Crohn's disease (12) Inflammatory bowel diseases (11) Human beings (11) cohorte (11) Ulcerative colitis (10) Swiss (10) Treatment (9) adulte (7) Methods (7) Diseases (7) Methods (7) adulte (7) thérapie (6) Therapeutics (6) âge (5) Manufacturers' agents (5) Evaluation (5) Commission merchants (5) Colitis (5) Older people (5) Age (5) Age (5) enquête (4) risque (4) Control (4) Inhibitors (4)

Documents écrit par P. Michetti (24) | parle de P. Michetti (0)

Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease.
M. Martinho-Grueber et al. (1 janv. 2023)
Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.
O. Mader et al.
Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel Disease.
L.F. Pittet et al. (2021)
ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study.
AGA Kolios et al.
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.
S. Godat et al.
Patient-reported healthcare expectations in inflammatory bowel diseases.
V. Pittet et al. (2018)
Mise au point sur la rectocolite ulcéro-hémorragique en 2017 [Management of ulcerative colitis in 2017]
E. Moschouri et al. (30 août 2017)
P298 Comparison between clinical and patient-reported symptoms among Crohn's disease and ulcerative colitis patients
V. Pittet et al. (1 févr. 2017)
Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator.
V. Pittet et al. (2017)
Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study.
P. Michetti et al.
A Look Beyond the Biosimilarity of the Molecules.
P. Michetti (2016)
Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort?
V. Pittet et al. (2016)
Systematic evaluation of clinical predictors of aggressive ulcerative colitis
S. Vavricka et al. (2015)
Prevalence of extraintestinal manifestations in paediatric patients with Inflammatory Bowel Disease : results from the Swiss IBD Cohort Study
S. Vavricka et al. (2015)
The management of iron deficiency in inflammatory bowel disease--an online tool developed by the RAND/UCLA appropriateness method.
W. Reinisch et al. (2013)
Macrophages promote epithelial repair through hepatocyte growth factor secretion.
D'Angelo F. et al. (2013)
Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia.
C. Felley et al.
Treatment algorithm for moderate to severe ulcerative colitis.
M. Manz et al. (27 juin 2011)
Development of the Crohn's disease digestive damage score, the Lémann score.
B. Pariente et al. (2011)
Fäkales Calprotectin bestimmen : Ein Biomarker, der für die Praxis taugt
C. Beglinger et al. (2011)
Recurrent Acute Pancreatitis and Therapy for Ulcerative Colitis.
J.L. Frossard et al. (2010)
Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).
V. Pittet et al. (2009)
The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells
M. H. Maillard et al.
Perceived behavioral changes in early multiple sclerosis.
F.S. Lima et al. (2007)